The incidence of acute gastrointestinal illness (AGI) attributable to public drinking water systems in the United States cannot be directly measured but must be estimated based on epidemiologic studies and other information. The randomized trial is one study design used to evaluate risks attributable to drinking water. In this paper, we review all published randomized trials of drinking water interventions in industrialized countries conducted among general immunocompetent populations. We then present an approach to estimating the incidence (number of cases) of AGI attributable annually to drinking water. To develop a national estimate, we integrate trial results with the estimated incidence of AGI using necessary assumptions about the estimated number of residents consuming different sources of drinking water and the relative quality of the water sources under different scenarios. Using this approach we estimate there to be 4.26-11.69 million cases of AGI annually attributable to public drinking water systems in the United States.
INTRODUCTION
Household drinking water intervention trials are used to investigate risks attributable to drinking water. In these trials one group of households typically is assigned randomly to use an in-home intervention device while another group uses a sham (or no other) device. These trials are similar to clinical trials to evaluate medical treatments comparing a drug to a placebo; in such water trials the sham water treatment device may be considered the placebo treatment. The incidence of gastrointestinal illness is recorded in each group. Under the assumption that the active group participants have no gastrointestinal illnesses attributable to water, the excess incidence of illnesses observed in the sham-device group theoretically represents the burden of waterborne disease and is called the attributable risk. Several such drinking water studies have been published using this design (Payment et al. 1991 (Payment et al. , 1997 Hellard et al. 2001; Colford et al. 2002 Colford et al. , 2005 .
In this paper, we first review the design and results of published drinking water trials conducted in industrialized countries in immunocompetent populations. This review intentionally focuses on household drinking water intervention trials conducted in countries with relatively high quality water supply and municipal water treatment similar to those seen in the United States. Studies in developing countries designed to address the efficacy of a specific treatment are not directly relevant to a US national estimate of waterborne disease and are not included in this review.
We then present an approach to estimate the incidence of endemic acute gastrointestinal illness (AGI) specifically attributable to drinking water. This approach combines the published estimates of risk attributable to drinking water based on information available from household drinking water trials, the estimates of total AGI and several estimates and assumptions about water consumption and source water quality for community water systems in the United States based on the best data currently available to us.
Estimates of the incidence of AGI in various populations can be obtained from many published studies. Roy et al. have provided estimates of acute gastrointestinal illness (due to infectious and noninfectious causes, excluding episodes of diarrhea or vomiting due to any long-lasting or chronic illness or condition) in the United States based on a comprehensive review of these published data, and we use these estimates (Roy et al. 2006) The proposed approach incorporates a range of estimates for the relative contributions of the source of water (such as groundwater or surface water), the water treatment system, and the distribution system. The framework uses available data whenever possible and assumptions when necessary. We then apply this approach to all currently available published data to arrive at an estimate of the number of cases of AGI attributable to drinking water annually in the United States.
We sought to develop an approach that could provide updated estimates of annual US episodes of AGI when additional data become available from new studies estimating waterborne attributable risk, new studies estimating AGI incidence, new surveys estimating the proportions of the population receiving drinking water from various sources across the country, and new estimates of the impact of the distribution system. This approach can subsequently be extended to estimate waterborne AGI incidence for specific sub-populations such as the elderly, children, the immunocompromised (e.g. cancer or HIV infection), when the necessary data are available for these specific subgroups.
PUBLISHED HOUSEHOLD DRINKING WATER INTERVENTION TRIALS
Through a literature search of MEDLINE and EMBASE (and searches of the bibliographies of relevant articles) we identified five published household interventions trials conducted in municipal water supplies whose results are relevant to the development of a national estimate of waterborne disease for the United States (Payment et al. 1991 (Payment et al. , 1997 Hellard et al. 2001; Colford et al. 2002 Colford et al. , 2005 . The key features of each of these studies are described in Table 1 and are reviewed briefly below. Trials that are underway currently were not eligible for inclusion. Payment et al. (1991) The first household intervention trial was conducted in the late 1980 s in a suburban area of Montreal. The area received tap water from a surface water source mainly contaminated by human sewage, but the treated water quality met or surpassed all Canadian and US regulatory standards.
Trials in Canada
In this trial, 299 eligible households were supplied with domestic water filters (reverse-osmosis) to eliminate microbial and chemical contaminants from their water, and 307 households were left with their usual tap water without a filter. Gastrointestinal symptoms were evaluated by means of a family health diary maintained prospectively by all study families over a 15-month period. The principal outcome measured was episodes of "highly credible gastrointestinal illness (HCGI)", defined as shown in 
Primary: Any of the following symptoms in a 24-h period: two or more loose stools, two or more episodes of vomiting, one loose stool together with abdominal pain or nausea or vomiting, or one episode of vomiting with abdominal pain or nausea. Secondary: two or more loose stools, one loose stool together with abdominal pain or nausea, one or more episodes of vomiting, or an episode of abdominal pain with nausea.
Blinding of participants GI illness: HCGI similar to Payment et al. (1991) .
GI illness: HCGI similar to Payment, 1991 observed a significant trend between the amount of water consumed and illness among those in the tap water group.
These findings were consistently observed in all population subgroups. The investigators estimated that, overall, 35% of the reported gastrointestinal illnesses among the tap water drinkers were drinking water-related and preventable.
The main potential limitation of this study with respect to its design was the lack of blinding: the tap water group participants were aware they had no reverse-osmosis device water with a continuously purged tap valve; and plant bottled water. The tap water group served as the exposed or baseline group, and the purified bottled water group served as the control, or unexposed, group. The tap water group with a purge valve was included to assess any relationship between illness and microbial regrowth in or contamination of the household water lines. The authors state: "It was postulated that, by maintaining a constant flow of water in the household pipes, water consumed by the subjects would be close in quality to water in the distribution system mains". The plant bottled water group was included to establish the contribution of the distribution system to the illness rate. The main outcome was HCGI (Table 1) . Over 350 households were initially enrolled in each treatment group. Overall, approximately 20% of participants dropped out of the study, but the bottled plant water group had a much higher dropout rate of 50%, with many citing taste and odor problems with the water as their primary reason for discontinuing the study. While low bacterial counts were found in the purified bottled water group, the plant bottled water group had extremely high heterotrophic plate counts with a geometric mean of over 1 million colony forming units per 100 ml.
The highest rates of illness were observed in the tapvalve group, followed by the tap group. The rate of illness in the plant bottled water group was no different than the rate of illness in the purified bottled water group despite the excessive regrowth of bacteria observed in the plant bottled water group. The attributable risk (AR) for the tap group was 0.08 (attributable risk percent [AR%] ¼ 12% and the AR for the tap valve group was 0.12 (AR% ¼ 17%).
The authors concluded that, because installation of a tap valve did not result in a lower rate of illness (in fact it resulted in a higher rate of illness compared to the tap water group), bacterial regrowth and contamination of the household pipes was not a likely cause of the excess illness. The authors speculated that since the rate of HCGI in the plant group was equivalent to or less than that in the purified bottled group the distribution system may have been the source of the differences observed, and that excess HCGI may be primarily due to distribution-related contamination rather than source water contamination.
This study had several limitations. There was a high dropout rate, particularly in the plant bottled water group, as discussed above, raising concerns regarding conclusions about this group. As in the first study, subjects were unblinded. The authors report that there was also a lower than expected compliance in the bottled water groups and that these groups frequently used other sources for their water.
Trials in Australia
Hellard et al. (2001) The first blinded household intervention trial was conducted in Australia. This study had different goals than the Payment studies and was conducted in an area of Melbourne that receives its water from protected catchments of high water quality. The community was considering adding filtration to the treatment process and the study was therefore designed to examine whether additional treatment would be effective in reducing the incidence of gastrointestinal illness.
This study addressed the issue of blinding by including a sham device. The treatment device was selected to have minimal effect on the taste of the water (ultraviolet treatment combined with 1-micron filtration) but which should have removed or inactivated waterborne pathogens.
The primary outcome differed slightly from Payment in that at least two loose stools and two episodes of vomiting were required for an AGI episode. Participants completed a weekly health diary for each of the 68 weeks of the study. Six hundred families with 2811 individuals were randomized.
There was a low dropout rate in this study, less than 7%.
After more than one year of follow up, the rates of illness in the treatment and sham groups were nearly identical. There was no difference in the type of fecal pathogens isolated from stool specimens in the two treatment arms. The authors also reported high compliance in that participants used the majority of their unboiled water from the treatment or sham device. The authors noted that water in the distribution system would not meet According to a previously published Blinding Index, participants were not able to successfully distinguish what type of water device they were assigned (James et al. 1996) .
The Blinding Index was 0.64; an index of 0.50 or above indicates successful blinding. Overall, more subjects tended to guess that they had received the active device.
In the sham-device group there were 103 episodes of HCGI and 10,790 days on which these subjects were at risk for HCGI ( The study concluded that subjects could be successfully blinded to an in-home water treatment device. Several criteria were used to select a study location: the entire community had to receive its drinking water from one microbiologically challenged surface water source; the source water had to be treated at one water treatment plant; the water had to be treated by conventional drinking water treatment methods to meet all US microbial regulatory standards, and the community had to be large enough to recruit for a study of 400 households. An additional consideration was the willingness of the utility to provide data on microbial water quality and treatment performance.
This trial was performed in Davenport, Iowa and its surrounding communities along the Mississippi River. whereby raw water bypassed sewage treatment and contaminated the source water supply. A related paper reported an increase in the incidence of HCGI during this time, but this increase occurred among study participants using both treatment and sham devices (Wade et al. 2004) .
The authors speculate that the reason for the lack of a difference in HCGI between the two study arms may be a result of the high quality of water treatment and the high quality of water throughout the distribution system. The authors also recognize that "conservative" biases such as consumption of water outside the home may have reduced the power of the study to detect an effect. The authors conclude that less than 10% of HCGI illness is attributable to water in a community with a well-operated municipal water utility using conventional treatment of surface water.
Although no differences were found among study groups, considerably higher rates of HCGI were observed in this study compared to the Payment and Hellard studies.
The reason for this is unknown since the outcomes were similarly defined. It is possible that these differences might be attributable to differences in water quality, water system vulnerability, water source and treatment, or other factors including consumption of water outside the home. Additionally, although there does exist a surveillance system for waterborne disease outbreaks, this system does not track endemic waterborne illness (Craun et al. 2006a) . We suggest here a procedure to estimate the incidence of acute gastrointestinal illness (AGI) occurring in community water systems in the United States that integrates the following estimates:
SUGGESTED APPROACH FOR THE ESTIMATION OF ACUTE GASTROINTESTINAL ILLNESS IN THE UNITED STATES ATTRIBUTABLE TO DRINKING WATER
(1) the estimated national incidence of AGI;
(2) the estimated proportion of these AGI cases attributable to drinking water derived from the randomized drinking water trials done in community water systems reviewed above;
(3) the estimated number of persons receiving drinking water from surface water versus groundwater sources in community water systems;
(4) the estimated proportion of the total risk for waterborne AGI attributable to problems with either the source water and water treatment (SW/TR) or attributable to problems with water arising from the distribution system (DS);
(5) the estimated proportion of the population consuming water from community systems with a history of water quality or treatment problems.
We have used published data for each of the estimates when such data were available. When no such data were available, we have made assumptions, stated the rationale for our choices, and examined the impact of these assumptions across a wide range of possible values. Using the Payment data, AR ¼ (0.66-0.58) ¼ 0.08 episodes/person-year. The AR may be thought of, and is sometimes referred to as, "excess risk" since the rate in the sham or tap water group is presumed to be greater than or equal to that in the treated group in a properly randomized trial in which the two groups differ only with respect to their drinking water (and in which there is no harmful effect from water treatment).
Estimated national incidence of AGI
Attributable risk percent (AR%) is a related measure which provides an estimate of the proportion of the total burden of HCGI among tap water drinkers is represented by the AR:
AR% ¼ ðAR=I Sham Þ £ 100:
In the Payment example, AR% ¼ (0.08/0.66) £ 100 ¼ 12%.
The assumption is that the remaining 88% of cases of HCGI are due to causes not related to the drinking water.
Using the five published trials of drinking water interventions conducted in general populations in Canada, Australia, and the United States, we make an initial estimate of the attributable risk for the general population (Payment et al. 1991 (Payment et al. , 1997 Hellard et al. 2001; Colford et al. 2002 Colford et al. , 2005 .
All of these trials involved consumption of tap water from surface water sources with varying levels of contamination and treatment. The AR in these studies ranged from a low of 0.14 (Colford et al. 2005 ) to a high of 0.85 (Colford et al. 2002) . The median AR of these five estimates is 0.08 with a median AR% of 12%. We use this median estimate of AR% ¼ 12% in our subsequent calculations. Because these studies were all conducted in sites using surface water as a source, a similar direct estimate of the proportion of cases due to contaminated groundwater is not possible. Instead, we assume that the AR% for groundwater systems is the same for surface water systems.
Estimated number of persons receiving water from drinking specific water sources (surface vs.
groundwater)
For the purposes of this estimate, we consider two components of the drinking water system, each of which may be responsible for a portion of the total risk: (1) the source water and its subsequent treatment (SW/TR), and
(2) the drinking water distribution system (DS The proportion of risk attributable to problems with source water or water treatment vs. problems with the distribution system
The proportion of risk for waterborne AGI that is attributable to contamination of water at the source or inadequate water treatment (SW/TR) is likely to be different than the proportion of risk attributable to contamination of water in the distribution system. However, the magnitudes of these proportions are unknown and assumptions must be made. We first assume that 90% of the risk for AGI is due to a contaminated water source or inadequate treatment (SW/TR) and that 10% is due to contamination of the drinking water in the distribution system (Table 2) . To evaluate the effect of the assumption of the distribution of risk between source water/treatment vs. distribution, in Table 3 we have reversed these estimates, assuming only a 10% risk for AGI due to a contaminated water source and 90% risk due to contamination in the distribution system.
The proportion of the population consuming high-risk drinking water
Not all source water, water treatment processes, and distribution systems are alike. Therefore, the risk of AGI also varies within each component of the drinking water system. One approach to characterizing high-risk drinking water is to base the characterization on whether it meets the standards of the US EPA national microbial drinking water regulations, i.e. the treatment technique requirements of the the TCR. For the following calculations, we will consider persons served by community water systems with the above violations in 2004 to be at high risk for AGI. All others will be considered to be at low risk for AGI. We will also assume that the risk varies by an order of magnitude (10-fold) between the high-risk category and the low-risk category.
SAMPLE ESTIMATE OF ACUTE GASTROINTESTINAL ILLNESS ATTRIBUTABLE TO COMMUNITY DRINKING WATER SYSTEMS IN THE UNITED STATES
In Tables 2 -6, using the methods and assumptions described above, we demonstrate an approach that can be used to estimate the annual incidence of endemic AGI cases attributable to community drinking water systems in the United States. These estimates exclude cases attributable to private water systems not regulated by the US EPA. These calculations rely on many assumptions and estimates, and the degree of uncertainty around these estimates is unknown. Furthermore, these calculations are made using only a limited number of relevant variables-other variables could be included in this approach if data were available.
Therefore, the estimates presented here are not meant to represent a rigorous evaluation of the risk for AGI. Rather, they are meant to illustrate a methodology that can and should be further refined as more data become available and to highlight data gaps where further research and investigation may be warranted.
Estimates of AGI due to community drinking water supplies in the population receiving surface water (Tables 2 and 3) In Table 2 we estimate the number of cases of AGI occurring among the 182.0 million people using community water systems (CWS) supplied by surface water, under the assumption that 90% of the risk was due to the source water or inadequate treatment (SW/TR) and that 10% of the risk was due to the distribution system. We first assumed that 7.6% (13.84 million) of the population was receiving highrisk surface water. We categorized the risks arising from the source water and treatment (SW/TR) and the risks from the distribution system as either "high" or "low" and assumed one order of magnitude of difference in these estimates. We then added the number of cases under all possible combinations of risks (high/low separately in the SW/TR and distribution systems) and estimated 2.93 million cases of AGI annually in those consuming surface water. In the second part of Table 2 we arbitrarily assumed that equal proportions of persons received water from high-and low-risk sources (i.e. 50%
received high-risk surface water rather than the 7.6% based on the violation data). Under this assumption, 7.81 million cases of AGI were estimated to occur annually. Estimates of AGI due to community drinking water supplies in the population receiving groundwater (Tables 4 and 5) We used 90.5 million as the estimated number of persons using community drinking water systems supplied by groundwater in the United States (SDWIS, 2004) . In Table 4 we assumed that 90% of the risk of illness was due to SW/ TR and 10% was due to the distribution system. Based on violation data, we also assumed that 5.4% (4.88 million) of the population received high-risk groundwater. As in the calculations for surface water (Tables 2 and 3) , we again divided the population into four groups based on the joint distribution of the SW/TR and distribution system risk.
Using these assumptions we estimate 1.33 million cases annually. In the second part of Table 4 , we arbitrarily assumed that 50% of the population (rather than 5.4%) received high-risk groundwater. Using these assumptions, 3.88 million cases of AGI were estimated to occur annually.
In Table 5 we reversed these assumptions and assumed that only 10% of the risk in groundwater systems was due to SW/TR while 90% of the risk was due to the distribution system. Under these assumptions, we estimate 3.60 million cases of AGI annually if 5.4% of the population received high-risk groundwater and 3.88 million cases of AGI if 50% of the population received high-risk groundwater.
Summary of groundwater and surface water risks
In there is a pressing need for better estimates of attributable risk due to waterborne disease in the setting of groundwater systems-we were forced to rely in this estimate entirely on data from trials conducted in surface water systems. We recommend calibration of the results of expensive household-level drinking water trials with other study designs such as community-intervention studies or observational studies which are much more easily conducted. The ability to develop reliable estimates from cheaper designs would make it possible to provide more estimates in more communities and subgroups.
Our estimate makes several simplifying assumptions.
One of these is that the generalization of the Attributable Risk percent (AR%) derived from intervention trials to the population level (Population Attributable Risk % or PAR%).
The AR% estimated by intervention trials is most applicable to those communities in which most residents primarily Table 2 Ground water 1.33 3.88 Table 4 Total 4.26 11.69
Scenario 2: 90% of the risk is associated with contamination in the distribution system Low estimate c High estimate d From Surface water 7.27 7.81 Table 3 Ground water 3.60 3.88 Table 5 Total 10.87 11.69 a Assumes 7.6% of the population uses high risk surface water sources, 5.4% of the population uses high risk ground water sources, and 90% of the risk is associated with the source water / treatment. drink tap water for their drinking water. In communities where a large proportion of residents already use treated (e.g. bottled or filtered) water, the AR% estimates from intervention trials may not apply and the use of a Population Attributable Risk percent (PAR%) would be more appropriate. This is yet another example where community-specific information on drinking water usage could be used to refine the estimate further.
Since the current estimate is based on population survey data obtained at several FoodNet sites across the country, the estimate could also be refined by weighting based on the types of water sources used by persons in the water from community drinking water systems supplied by surface water and groundwater sources. The degree of uncertainty in this estimate is unknown but this approach makes explicit the assumptions that are applied and the additional data that could be gathered to improve the estimation. We caution that this approach can and should be refined for specific populations (e.g. the immunocompromised, the young, the elderly) or specific communities as additional data become available. Our approach and current estimates will be updated as appropriate new data become available.
